Sector portfolio · Private equity · United States
Franklin Templeton's Biotech portfolio
Franklin Templeton has backed 11 Biotech startups in rounds we track, $3.8B between them, shown by the stage each has reached. The best-funded is Eqrx.
Franklin Templeton's whole portfolioFranklin Templeton's profile
Funding by segment
- Stage not reported$3.3B8
- Series C and later$517M3
Where they are based
- United States11$3.8B
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M0
- $50M to $250M5
- $250M to $1B4
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States11
Startups by country, 1 country in all.
Segment by segment
Stage not reported
8 startups · $3.3B raised
EQRxEQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.United States$1.2B
Candid TherapeuticsCandid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.United States$875M
Taysha Gene TherapiesTaysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.United States$400M
Allogene TherapeuticsAllogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.United States$310M
Centessa PharmaceuticalsCentessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.United States$250M
True North TherapeuticsTrue North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.United States$142M
Athira PharmaAt Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, Parkinson’s diUnited States$90M
Nautilus BiotechnologyNautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.United States$1.6M
Series C and later
3 startups · $517M raised
Lycia TherapeuticsLycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California.United States$182M
MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
BenchlingBenchling is a cloud-based platform for biotechnology research and development and the only biology-first platform for scientific United States$162M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Franklin Templeton as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Franklin Templeton?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.